From January 28, 2022 to March 31, 2022, the company has repurchased 220,001 shares, representing 0.78% for KRW 1,670.83 million. With this, the company has completed the repurchase of 220,001 shares, representing 0.78% for KRW 1,670.83 million under the buyback announced on January 28, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,960 KRW | +1.16% | -11.68% | +22.97% |
1st Jan change | Capi. | |
---|---|---|
+22.97% | 138M | |
+37.43% | 727B | |
-7.85% | 354B | |
+15.63% | 328B | |
-0.49% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+3.90% | 164B | |
-1.98% | 164B |
- Stock Market
- Equities
- A006620 Stock
- News DongKoo Bio & Pharma Co., Ltd.
- Tranche Update on DongKoo Bio&Pharma Co., Ltd.'s Equity Buyback Plan announced on January 28, 2022.